|
|
Prenatal Tobacco Exposure: Self-Regulatory Pathways to Externalizing Behaviors |
| 5 K01 DA048135-02 |
MICALIZZI, LAUREN GIOIA |
NIDA |
2021 |
|
|
Multi-level associations between opioid use and overdose: Individual, clinical, and population-based risk factors for fatality |
| 5 K01 DA049950-02 |
SAMPLES, HILLARY |
NIDA |
2021 |
|
|
Electroretinogram: a new human biomarker for smoking cessation treatment |
| 5 K23 DA042136-05 |
LUO, SEAN XIAO |
NIDA |
2021 |
|
|
Cognitive Recovery With Cannabis Abstinence Among High School-Aged Adolescents |
| 5 K23 DA042946-05 |
SCHUSTER, RANDI MELISSA |
NIDA |
2021 |
|
|
Early Stress and the Neurobiology of Susceptibility and Resilience to Substance Use Disorders |
| 5 R01 DA017846-12 |
TEICHER, MARTIN H |
NIDA |
2021 |
|
|
Effectiveness, toxicity and safety of opioid and benzodiazepine substitutes |
| 5 R01 DA039192-06 |
KUO, YONG-FANG |
NIDA |
2021 |
|
|
Testing an integrated bio-behavioral primary HIV prevention intervention among high-risk people who use drugs |
| 5 R01 DA044867-05 |
COPENHAVER, MICHAEL |
NIDA |
2021 |
|
|
Targeting the Cholinergic Pathway in HIV-associated Inflammation and Cognitive Dysfunction |
| 5 R01 DA044906-05 |
ASHARE, REBECCA |
NIDA |
2021 |
|
|
MRI data fusion to investigate effects of drug abuse on HIV neurological complications |
| 5 R01 DA045565-04 |
MEADE, CHRISTINA S |
NIDA |
2021 |
|
|
Randomized Controlled Trial of a Novel Smoking Cessation Application Tailored to Individuals with Serious Mental Illness |
| 5 R01 DA047301-02 |
VILARDAGA, ROGER |
NIDA |
2021 |
